ArticleHepatology international2026

Circulating cfDNA CD86 methylation is associated with durable response to atezolizumab-bevacizumab in hepatocellular carcinoma.

Akimitsu Meno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.